SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NVCT

Nuvectis Pharma, Inc. (NASDAQ:NVCT)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$19.39-$0.45 (-2.27%)
 
Market cap
$667M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 4, 2022
Market Cap$666.80M+218.9%
Revenue (ttm)$0
Net Income-$50.45M-98.8%
EPS-$1.89-40.0%
Shares Out34.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume301,603
Open$19.81
Previous Close$19.84
Day's Range$19.05 - $20.09
52-Week Range$5.77 - $29.28
Betan/a
AnalystsBuy
Price Target$37.33(+92.52%)
Earnings DateFeb 10, 2027

About NVCT

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.

Address
1 Bridge Plaza, Fort Lee, NJ, 07024, US
Market Cap
667 million
Employees
19
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$2.29M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $40.00 (+106.3%)

1 firm rating NVCT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From NVCT’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-2.27%
5 Days
-3.05%
1 Month
-6.33%
6 Months
+77.24%
1 Year
+218.91%

$NVCT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NVCT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NVCT's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NVCT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

NVCT Revenue by Segment

$55.42MTotal
Segment Loss$30.07M54.26%
License Fees$21.80M39.34%
Professional Fees$2.29M4.12%
Insurance and other$722.00K1.30%
Manufacturing$545.00K0.98%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New NVCT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NVCT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in NVCT

IWMiShares Russell 2000 ETF$11.00M
VTIVanguard Morningstar Total Stock Market ETF$9.47M
VXFVanguard Extended Market ETF$4.40M
IWOiShares Russell 2000 Growth ETF$4.00M
VTWOVanguard Russell 2000 ETF$2.27M
FESMFidelity Enhanced Small Cap ETF$2.13M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from NVCT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
8
Sells
0
Buy Value
$2.29M
Distinct Buyers
4

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

DWASInvesco Dorsey Wright SmallCap Momentum ETF0.41%
IWCiShares Micro-Cap ETF0.11%
FESMFidelity Enhanced Small Cap ETF0.03%

Weight is the stock’s share of each fund’s holdings.